Named as a key player in 231 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Healthcare In Vitro Diagnostic | Healthcare Services | $83.5 Bn | 3.8% |
| Point of Care Diagnostics | Digital Health | $45.4 Bn | 7.4% |
| Point Of Care (PoC) Molecular Diagnostic | Healthcare Services | $18.7 Bn | 9.3% |
| Nursing Education | Healthcare Services | $10.3 Bn | 8.1% |
| Breast Cancer Diagnostic | Healthcare Services | $4.1 Bn | 7.8% |
| Brain Cancer Diagnostic | Healthcare Services | $1.5 Bn | 13.6% |
| Antimicrobial Susceptibility Testing | Healthcare Services | – | – |
Named as key players in the same markets as bioMérieux SA (number of shared markets).
Siemens Healthineers6 shared markets
Thermo Fisher Scientific Inc.6 shared markets
Abbott Laboratories5 shared markets
Danaher Corporation4 shared markets
Roche Diagnostics4 shared markets
Becton, Dickinson and Company (BD)3 shared markets
Agilent Technologies2 shared markets
Becton, Dickinson and Company2 shared markets